• EdU Imaging Kits: Practical Proliferation Workflows

  2026-08-13

  EdU Imaging Kits (HF488) convert S-phase DNA synthesis into a sensitive fluorescence readout for microscopy and flow cytometry. This guide connects the assay to RCC drug-response studies, combination testing, cell-cycle profiling, and practical troubleshooting beyond conventional BrdU workflows.

• Nanoplastic–Cadmium Apoptosis via IP3R/Ca2+/STAT3

  2026-08-13

  A 2026 Toxicology study links polystyrene nanoplastic–cadmium co-exposure to intestinal apoptosis through an IP3R/Ca2+/STAT3 signaling axis. By combining C. elegans, Caco-2 cells, and pathway-directed inhibitors, the work positions calcium mobilization as a mechanistic connection between environmental co-exposure, endoplasmic reticulum stress, and cell death.

• TGF-β, Sca-1, and Mammary Cell Plasticity

  2026-08-12

  The reference study shows that TGF-β dynamically regulates Sca-1 expression while reshaping lineage commitment and tumor-initiating potential in mouse mammary epithelial models. Its central contribution is the separation of endogenous Smad2/3/4-dependent Sca-1 repression from an exogenous TGF-β response that does not require Smad2/3, providing a mechanistic framework for studying epithelial plasticity.

• Fucoidan, Caveolin-1, and MCF-7 Breast Cancer

  2026-08-12

  A 2026 study identifies Caveolin-1 downregulation as a potential component of fucoidan-mediated tumor suppression in MCF-7 breast cancer cells. By comparing fucoidan with Tamoxifen across cytotoxicity, colony formation, migration, and Caveolin-1 expression assays, the work provides a useful in vitro framework for evaluating marine polysaccharides while emphasizing the need for causal and in vivo validation.

• Catalpol: From Mechanism to Translation

  2026-08-11

  Catalpol, also known as Catalpinoside, is emerging as a multi-pathway research tool for connecting oxidative stress, neuroinflammation, tissue repair, and disease-model outcomes. This thought-leadership article examines the mechanistic evidence, protocol considerations, translational barriers, and strategic opportunities for using Catalpol in neuroprotection research and broader preclinical programs.

• I-BET151 (GSK1210151A) Assay Workflow Guide

  2026-08-11

  This guide explains how to plan, prepare, and quality-control I-BET151 (GSK1210151A) for BET bromodomain inhibition studies, including apoptosis and cell cycle arrest assays. It is intended for controlled research workflows only and should not be used for diagnostic, therapeutic, or clinical applications.

• Eltanexor: From Nuclear Export to CRC Assays

  2026-08-10

  Eltanexor (KPT-8602) is an oral XPO1 inhibitor with applications spanning leukemia research and colorectal cancer models. This article presents a mechanism-to-assay framework that connects nuclear protein retention, Wnt/β-catenin signaling, organoid sensitivity, and translational study design.

• LEE011 Succinate: pH-Aware CDK4/6 Assays

  2026-08-09

  LEE011 succinate is more than a selective CDK inhibitor: its pH-dependent solubility can shape assay reproducibility. This guide connects ribociclib mechanism, dynamic dissolution data, and practical cancer research workflows.

• Fluoxetine HCl for Motivation Research

  2026-08-08

  Use Fluoxetine HCl to connect serotonergic transporter activity with receptor signaling, reward behavior, and plasticity endpoints. This workflow emphasizes assay-specific controls, adolescent motivation testing, and troubleshooting for reproducible depression research.

• Cl-Amidine: Designing Mechanistic Cancer Assays

  2026-08-07

  Cl-Amidine trifluoroacetate salt enables researchers to separate PAD4-dependent histone citrullination from cell-cycle and apoptosis effects in cancer research. This guide applies lessons from a VHL-deficient renal carcinoma study to build better mechanistic assays without overstating cross-model evidence.

• Z-VAD-FMK: Beyond Apoptosis—Precision in Cell Death Pathway

  2026-08-07

  Discover how Z-VAD-FMK empowers advanced apoptosis inhibition and caspase activity measurement, uniquely bridging caspase-dependent and -independent cell death research. This in-depth guide reveals new practical insights for experimental design beyond standard protocols.

• GPR107 Deficiency Drives Collagen IV Accumulation in Diabeti

  2026-08-06

  Xu et al. (2025) reveal that GPR107 deficiency in podocytes impairs clathrin-mediated endocytosis of the angiotensin II receptor, leading to dysregulated calcium signaling and pathological collagen IV accumulation in diabetic nephropathy. This study clarifies a mechanistic link between endocytic trafficking, calcium signaling, and extracellular matrix remodeling, positioning GPR107 as a potential therapeutic target for diabetic kidney disease.

• Cy5-UTP: Advanced RNA Labeling for In Vitro Transcription

  2026-08-06

  Cy5-UTP (Cyanine 5-UTP) revolutionizes RNA probe synthesis by enabling single-step, high-sensitivity fluorescent labeling during in vitro transcription. Its robust orange fluorescence streamlines FISH, dual-color expression arrays, and mechanistic studies, minimizing workflow complexity and maximizing detection power.

• Ordered DNA Nanostructures Enhance Enzymatic DNA Synthesis E

  2026-08-05

  The referenced study introduces a tetrahedral DNA nanostructure (TDN) interface to improve enzymatic oligonucleotide synthesis (EOS), achieving higher yield and fidelity compared to conventional approaches. This innovation addresses longstanding barriers of enzyme accessibility and deletion errors, with implications for DNA storage, advanced probe design, and high-precision nucleic acid detection.

• Scenario-Driven Best Practices with Reactive Oxygen Species

  2026-08-05

  This article addresses persistent challenges in oxidative stress research, guiding scientists through real-world scenarios where the Reactive Oxygen Species Assay Kit (SKU K2065) streamlines ROS detection, enhances data reliability, and supports reproducibility. Discover how DCFH-DA fluorescent probe chemistry and rigorous controls enable robust cellular ROS level quantification, with actionable protocol and vendor insights for biomedical labs.

7997 records 2/534 page Previous Next 12345 下5页 Last page